1. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway
   Qiong Xu et al, 2020, Experimental Cell Research CrossRef
2. Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer
   Dipti Kanabar et al, 2022, Journal of Medicinal Chemistry CrossRef
3. Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
   Chengxing Wang et al, 2021, Frontiers in Oncology CrossRef
4. The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin
   Xiaoliang Xu et al, 2019, Cell Death & Disease CrossRef
5. Gankyrin regulates cell signaling network
   Xinxin Wang et al, 2016, Tumor Biology CrossRef
6. Synthesis and Evaluation of 2,5-Substituted Pyrimidines as Small-Molecule Gankyrin Binders
   Dipti Kanabar et al, 2024, Future Medicinal Chemistry CrossRef
7. TGF-β1 signaling pathway serves a role in HepG2 cell regulation by affecting the protein expression of PCNA, gankyrin, p115, XIAP and survivin
   Xin-Hong Wang et al, 2017, Oncology Letters CrossRef
8. Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma
   Parvin Zamani et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
9. Gankyrin as a potential therapeutic target for cancer
   Chongchong Wang et al, 2017, Investigational New Drugs CrossRef
10. Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses
    Maria K. Tveitarås et al, 2017, Experimental Cell Research CrossRef
11. Gankyrin: At the crossroads of cancer diagnosis, disease prognosis, and development of efficient cancer therapeutics
    Dharmendra Kashyap et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
12. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells
    Ming Lei et al, 2023, Scientific Reports CrossRef
13. Decreased E‐Cadherin in MCF7 Human Breast Cancer Cells Forming Multicellular Spheroids Exposed to Simulated Microgravity
    Jayashree Sahana et al, 2018, PROTEOMICS CrossRef
14. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells
    Maria E. Camacho-Moll et al, 2019, BMC Cancer CrossRef
15. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer
    Wu-ping Wang et al, 2015, Pathology - Research and Practice CrossRef
16. IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling
    Xing-Yu Pu et al, 2018, Hepatobiliary & Pancreatic Diseases International CrossRef
17. Overexpression of p28GANK accelerates the metastasis of oesophageal squamous cell carcinoma
    SHANHONG TANG et al, 2015, Molecular Medicine Reports CrossRef
18. MiR‐605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression
    Jianwei Li et al, 2014, FEBS Letters CrossRef
19. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway
    Wu-ping Wang et al, 2017, Oncotarget CrossRef
20. Identification of a covalent binder to the oncoprotein gankyrin using a NIR-Based OBOC screening method
    Marianne E. Maresh et al, 2021, RSC Advances CrossRef
21. HIF-1α: Its Role in Metastasis of Oesophageal Malignancy
    A. M. V. N. Prathyusha et al, 2017, Role of Transcription Factors in Gastrointestinal Malignancies CrossRef